Align Technology, Inc. (NASDAQ:ALGN) will issue its quarterly earnings data after the market closes on Thursday, October 26th. Analysts expect the company to announce earnings of $0.79 per share for the quarter. Align Technology has set its Q3 guidance at $0.79-0.82 EPS.
Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.85 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.12. Align Technology had a return on equity of 23.87% and a net margin of 19.18%. The business had revenue of $356.50 million during the quarter, compared to the consensus estimate of $343.43 million. During the same period in the previous year, the business earned $0.62 EPS. The business’s quarterly revenue was up 32.3% on a year-over-year basis. On average, analysts expect Align Technology to post $3.41 EPS for the current fiscal year and $4.05 EPS for the next fiscal year.
Shares of Align Technology, Inc. (ALGN) opened at 203.72 on Wednesday. The company has a market capitalization of $16.33 billion, a P/E ratio of 69.77 and a beta of 1.54. Align Technology, Inc. has a one year low of $83.27 and a one year high of $205.99. The stock has a 50 day moving average price of $188.21 and a 200-day moving average price of $159.61.
ALGN has been the subject of a number of recent research reports. Zacks Investment Research cut Align Technology from a “strong-buy” rating to a “hold” rating in a report on Monday, August 21st. Morgan Stanley reissued an “overweight” rating and issued a $220.00 target price (up from $195.00) on shares of Align Technology in a report on Friday, October 6th. Stifel Nicolaus reissued a “buy” rating and issued a $225.00 target price (up from $205.00) on shares of Align Technology in a report on Thursday, October 19th. Northcoast Research reissued a “buy” rating and issued a $230.00 target price (up from $200.00) on shares of Align Technology in a report on Tuesday, October 10th. Finally, Robert W. Baird reissued a “buy” rating on shares of Align Technology in a report on Tuesday, September 12th. One research analyst has rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $200.50.
About Align Technology
Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.
Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.